Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases

Antioxidants and Redox Signaling

Volumn 18, Issue 5, 2013, Pages 507-521

  Barbagallo, Ignazio ^a   Galvano, Fabio ^a   Frigiola, Alessandro ^b   Cappello, Francesco ^c,d,e   Riccioni, Graziano ^f   Murabito, Paolo ^a   D'orazio, Nicolantonio ^g   Torella, Michele ^h   Gazzolo, Diego ^b,i   Li Volti, Giovanni ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Euromediterranean Institute of Science and Technology ^*  (Italy)

^e Department of Veterinary Medical Sciences   (Switzerland)

^f SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^g UNIVERSITY OF CHIETI   (Italy)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

ⁱ C Arrigo Children's Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTHOCYANIN; ANTIOXIDANT; ASCORBIC ACID; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BETA CAROTENE; CAFFEIC ACID PHENETHYL ESTER; CURCUMIN; CYANIDIN 3 GLUCOSIDE; DELPHINIDIN; ENTEROLACTONE; EPIGALLOCATECHIN GALLATE; ESCULETIN; FLAVONOID; HEME OXYGENASE 1; HEMIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MAGNESIUM LITHOSPERMATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLANT EXTRACT; POLYPHENOL; PROBUCOL; QUERCETIN DERIVATIVE; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UBIDECARENONE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ATHEROSCLEROSIS; CANCER CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CELL PROTECTION; CELL SURVIVAL; CYTOPLASM; DRUG STRUCTURE; ENZYME ACTIVITY; FRAXINUS; FRAXINUS RHYNCHOPHYLLA; HUMAN; METHYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDOX STRESS; REVIEW; TRANSCRIPTION REGULATION;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; OXIDATIVE STRESS;

EID: 84872183989     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4360     Document Type: Review

References (156)

1. Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, and Kryscio RJ. Vitamin E and all-cause mortality: a metaanalysis. Curr Aging Sci 4: 158-170, 2011.
2. Abrescia P and Golino P. Free radicals and antioxidants in cardiovascular diseases. Expert Rev Cardiovasc Ther 3: 159-171, 2005.
3. Alam J, Igarashi K, Immenschuh S, Shibahara S, and Tyrrell RM. Regulation of heme oxygenase-1 gene transcription: recent advances and highlights from the International Conference (Uppsala, 2003) on Heme Oxygenase. Antioxid Redox Signal 6: 924-933, 2004.
4. Awede B, Lemaire MC, Hyvelin JM, Halimi JM, Bonnet P, and Eder V. Hemin, a carbon monoxide donor, improves systemic vascular compliance by inhibiting the RhoARhokinase pathway in spontaneous hypertensive rats. Eur J Pharmacol 626: 256-261, 2010.
5. Axelson M and Setchell KD. The excretion of lignans in rats - evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 123: 337-342, 1981. (Pubitemid 11148771)
6. Azorin-Ortuno M, Yanez-Gascon MJ, Vallejo F, Pallares FJ, Larrosa M, Lucas R, Morales JC, Tomas-Barberan FA, Garcia-Conesa MT, and Espin JC. Metabolites and tissue distribution of resveratrol in the pig. Mol Nutr Food Res 55: 1154-1168, 2011.
7. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, and Motterlini R. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidantresponsive element. Biochem J 371: 887-895, 2003. (Pubitemid 36578887)
8. Bastianetto S and Quirion R. Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp Neurol 225: 237-239, 2010.
9. Berrougui H, Grenier G, Loued S, Drouin G, and Khalil A. A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux. Atherosclerosis 207: 420-427 2009.
10. Bertelli AA and Das DK. Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 54: 468-476, 2009.
11. Bhandarkar SS and Arbiser JL. Curcumin as an inhibitor of angiogenesis. Adv Exp Med Biol 595: 185-195, 2007.
12. Bradamante S, Barenghi L, and Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22: 169-188, 2004. (Pubitemid 39391187)
13. Calabrese V, Cornelius C, Trovato A, Cavallaro M, Mancuso C, Di Rienzo L, Condorelli D, De Lorenzo A, and Calabrese EJ. The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des 16: 877-883 2010.
14. Cao J, Sodhi K, Inoue K, Quilley J, Rezzani R, Rodella L, Vanella L, Germinario L, Stec DE, Abraham NG, and Kappas A. Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum Gene Ther 22: 271-282 2011.
15. Cao J, Sodhi K, Puri N, Monu SR, Rezzani R, and Abraham NG. High fat diet enhances cardiac abnormalities in SHR rats: protective role of heme oxygenase-adiponectin axis. Diabetol Metab Syndr 3: 37, 2011.
16. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9: 161-168, 2003. (Pubitemid 36297021)
17. Chan AY, Dolinsky VW, Soltys CL, Viollet B, Baksh S, Light PE, and Dyck Jr. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 283: 24194-24201, 2008.
18. Chen CG and Wang YP. Magnesium lithospermate B ameliorates renal cortical microperfusion in rats. Acta Pharmacol Sin 27: 217-222, 2006.
19. Chen J, Bai H,Wang C, and Kang J. Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells. Pharmazie 61: 710-716, 2006. (Pubitemid 44298929)
20. Chen YC, Chow JM, Lin CW, Wu CY, and Shen SC. Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. Toxicol Appl Pharmacol 216: 263-273, 2006.
21. Chrissobolis S, Miller AA, Drummond GR, Kemp-Harper BK, and Sobey CG. Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci 16: 1733-1745, 2011.
22. Chu LM, Lassaletta AD, Robich MP, and Sellke FW. Resveratrol in the prevention and treatment of coronary artery disease. Curr Atheroscler Rep 13: 439-446, 2011.
23. Chung JH, Han JH, Hwang EJ, Seo JY, Cho KH, Kim KH, Youn JI, and Eun HC. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J 17: 1913-1915, 2003.
24. Cos P, Rajan P, Vedernikova I, Calomme M, Pieters L, Vlietinck AJ, Augustyns K, Haemers A, and Vanden Berghe D. In vitro antioxidant profile of phenolic acid derivatives. Free Radic Res 36: 711-716, 2002. (Pubitemid 34567346)
25. Csiszar A. Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease. Ann N Y Acad Sci 1215: 117-122, 2011.
26. Cullen JP, Morrow D, Jin Y, Curley B, Robinson A, Sitzmann JV, Cahill PA, and Redmond EM. Resveratrol, a polyphenolic phytostilbene, inhibits endothelial monocyte chemotactic protein-1 synthesis and secretion. J Vasc Res 44: 75-84, 2007. (Pubitemid 46105695)
27. Das S, Cordis GA, Maulik N, and Das DK. Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol 288: H328-H335, 2005. (Pubitemid 40023863)
28. De Amicis F, Giordano F, Vivacqua A, Pellegrino M, Panno ML, Tramontano D, Fuqua SA, and Ando S. Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor {alpha} gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB J 25: 3695-3707, 2011.
29. de la Lastra CA and Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35: 1156-1160, 2007. (Pubitemid 350206449)
30. Desbuards N, Rochefort GY, Schlecht D, Machet MC, Halimi JM, Eder V, Hyvelin JM, and Antier D. Heme oxygenase-1 inducer hemin prevents vascular thrombosis. Thromb Haemost 98: 614-620, 2007. (Pubitemid 47412887)
31. Do GM, Kwon EY, Kim HJ, Jeon SM, Ha TY, Park T, and Choi MS. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun 374: 55-59, 2008.
32. Du D, Chang S, Chen B, Zhou H, and Chen ZK. Adenovirus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants. Transplant Proc 39: 3446-3448, 2007. (Pubitemid 350251447)
33. Durante W. Targeting heme oxygenase-1 in vascular disease. Curr Drug Targets 11: 1504-1516, 2010.
34. Elahi MM, Kong YX, and Matata BM. Oxidative stress as a mediator of cardiovascular disease. Oxid Med Cell Longev 2: 259-269, 2009.
35. Escalante B, Sacerdoti D, Davidian MM, Laniado-Schwartzman M, and McGiff JC. Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 17: 776-779, 1991.
36. Ewing P, Wilke A, Eissner G, Holler E, Andreesen R, and Gerbitz A. Expression of heme oxygenase-1 protects endothelial cells from irradiation-induced apoptosis. Endothelium 12: 113-119, 2005. (Pubitemid 41535018)
37. Fabre KM, Saito K, DeGraff W, Sowers AL, Thetford A, Cook JA, Krishna MC, and Mitchell JB. The effects of resveratrol and selected metabolites on the radiation and antioxidant response. Cancer Biol Ther 12: 915-923, 2011.
38. Favreau LV and Pickett CB. The rat quinone reductase antioxidant response element. Identification of the nucleotide sequence required for basal and inducible activity and detection of antioxidant response element-binding proteins in hepatoma and non-hepatoma cell lines.JBiolChem270: 24468-24474, 1995.
39. Ferrandiz ML and Devesa I. Inducers of heme oxygenase-1. Curr Pharm Des 14: 473-486, 2008. (Pubitemid 351516852)
40. Fish JM, Welchons DR, Kim YS, Lee SH, Ho WK, and Antzelevitch C. Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 113: 1393-1400, 2006. (Pubitemid 43739435)
41. Florczyk U, Loboda A, Stachurska A, Jozkowicz A, and Dulak J. [Role of Nrf2 transcription factor in cellular response to oxidative stress]. Postepy Biochem 56: 147-155, 2010.
42. Giudice A, Arra C, and Turco MC. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol Biol 647: 37-74, 2010.
43. Gu J, Song ZP, Gui DM, Hu W, Chen YG, and Zhang DD. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in lymphoma nude mice by heme oxygenase-1 induction. Cardiovasc Toxicol 2012 [Epub ahead of print] DOI: 10.1007/s12012-012-9178-7.
44. Harikumar KB and Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7: 1020-1035, 2008.
45. Hayes JD and McMahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 174: 103-113, 2001. (Pubitemid 33026113)
46. Hirooka Y. Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension. Hypertens Res 34: 407-412, 2011.
47. Hishikawa K, Nakaki T, and Fujita T. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25: 442-446, 2005. (Pubitemid 40189171)
48. Holthoff JH, Woodling KA, Doerge DR, Burns ST, Hinson JA, and Mayeux PR. Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite. Biochem Pharmacol 80: 1260-1265, 2010.
49. Hu FB and Willett WC. Optimal diets for prevention of coronary heart disease. JAMA 288: 2569-2578, 2002. (Pubitemid 35386892)
50. Huang HC, Lai MW, Wang HR, Chung YL, Hsieh LM, and Chen CC. Antiproliferative effect of esculetin on vascular smooth muscle cells: possible roles of signal transduction pathways. Eur J Pharmacol 237: 39-44, 1993.
51. Huang SH, Chu CH, Yu JC, Chuang WC, Lin GJ, Chen PL, Chou FC, Chau LY, and Sytwu HK. Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects nonobese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation. Diabetologia 53: 2389-2400, 2010.
52. Ichiyanagi T, Rahman MM, Kashiwada Y, Ikeshiro Y, Shida Y, Hatano Y, Matsumoto H, Hirayama M, and Konishi T. Absorption and metabolism of delphinidin 3-O-beta-D-glucoside in rats. Biofactors 21: 411-413, 2004. (Pubitemid 40921895)
53. Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, and Forman HJ. HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic Biol Med 39: 355-364, 2005. (Pubitemid 40910192)
54. Jensen GS, Wu X, Patterson KM, Barnes J, Carter SG, Scherwitz L, Beaman R, Endres JR, and Schauss AG. In vitro and in vivo antioxidant and anti-inflammatory capacities of an antioxidant-rich fruit and berry juice blend. Results of a pilot and randomized, double-blinded, placebo-controlled, crossover study. J Agric Food Chem 56: 8326-8333, 2008.
55. Jeon EM, Choi HC, Lee KY, Chang KC, and Kang YJ. Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21. Arch Pharm Res 32: 375-382, 2009.
56. Jeong GS, Oh GS, Pae HO, Jeong SO, Kim YC, Shin MK, Seo BY, Han SY, Lee HS, Jeong JG, Koh JS, and Chung HT. Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection. Exp Mol Med 38: 393-400, 2006. (Pubitemid 44390517)
57. Jiang JH, Jin CM, Kim YC, Kim HS, Park WC, and Park H. Anti-toxoplasmosis effects of oleuropein isolated from Fraxinus rhychophylla. Biol Pharm Bull 31: 2273-2276, 2008.
58. Johns DG, Zelent D, Ao Z, Bradley BT, Cooke A, Contino L, Hu E, Douglas SA, and Jaye MC. Heme-oxygenase induction inhibits arteriolar thrombosis in vivo: effect of the nonsubstrate inducer cobalt protoporphyrin. Eur J Pharmacol 606: 109-114, 2009.
59. Juan SH, Cheng TH, Lin HC, Chu YL, and Lee WS. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem Pharmacol 69: 41-48, 2005.
60. Kaga S, Zhan L, Matsumoto M, and Maulik N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39: 813-822, 2005. (Pubitemid 41464418)
61. Kang YJ. New understanding in cardiotoxicity. Curr Opin Drug Discov Devel 6: 110-116, 2003. (Pubitemid 36206945)
62. Katori M, Buelow R, Ke B, Ma J, Coito AJ, Iyer S, Southard D, Busuttil RW, and Kupiec-Weglinski JW. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 73: 287-292, 2002. (Pubitemid 34112855)
63. Kawamoto S, Flynn JP, Shi Q, Sakr SW, Luo J, and Allen MD. Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo. Tissue Eng Part A 17: 1605-1614, 2011.
64. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, and Maruyama Y. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25: 155-160, 2005. (Pubitemid 40054269)
65. Kim AN, Jeon WK, Lee JJ, and Kim BC. Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radic Biol Med 49: 323-331, 2010.
66. Kim JW, Lim SC, Lee MY, Lee JW, Oh WK, Kim SK, and Kang KW. Inhibition of neointimal formation by transresveratrol: role of phosphatidyl inositol 3-kinase-dependent Nrf2 activation in heme oxygenase-1 induction. Mol Nutr Food Res 54: 1497-1505, 2010.
67. Kim NY, Pae HO, Ko YS, Yoo JC, Choi BM, Jun CD, Chung HT, Inagaki M, Higuchi R, and Kim YC. In vitro inducible nitric oxide synthesis inhibitory active constituents from Fraxinus rhynchophylla. Planta Med 65: 656-658, 1999. (Pubitemid 29503236)
68. Kim SH, Choi M, Lee Y, Kim YO, Ahn DS, Kim YH, Kang ES, Lee EJ, Jung M, Cho JW, Williams DR, and Lee HC. Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction. Cardiovasc Res 87: 713-722, 2010.
69. Kitts DD, Yuan YV, Wijewickreme AN, and Thompson LU. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202: 91-100 1999. (Pubitemid 30099742)
70. Kivela AM, Kansanen E, Jyrkkanen HK, Nurmi T, Yla-Herttuala S, and Levonen AL. Enterolactone induces heme oxygenase-1 expression through nuclear factor-E2-related factor 2 activation in endothelial cells. J Nutr 138: 1263-1268, 2008. (Pubitemid 351930987)
71. Klaunig JE, Wang Z, Pu X, and Zhou S. Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol 254: 86-99, 2011.
72. Kong JM, Chia LS, Goh NK, Chia TF, and Brouillard R. Analysis and biological activities of anthocyanins. Phytochemistry 64: 923-933, 2003. (Pubitemid 37295344)
73. Kostyuk VA and Potapovich AI. Mechanisms of the suppression of free radical overproduction by antioxidants. Front Biosci (Elite Ed) 1: 179-188, 2009.
74. Kroon PA, Iyer A, Chunduri P, Chan V, and Brown L. The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential. Curr Med Chem 17: 2442-2455, 2010.
75. Krzyzanowska J, Czubacka A, and Oleszek W. Dietary phytochemicals and human health. Adv Exp Med Biol 698: 74-98, 2010.
76. Kudugunti SK, Thorsheim H, Yousef MS, Guan L, and Moridani MY. The metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase. Chem Biol Interact 192: 243-256, 2011.
77. Kuriyama S. Green tea consumption and prevention of coronary artery disease. Circ J 74: 248-249, 2010.
78. Kushida T, Li Volti G, Quan S, Goodman A, and Abraham NG. Role of human heme oxygenase-1 in attenuating TNF-alpha-mediated inflammation injury in endothelial cells. J Cell Biochem 87: 377-385, 2002. (Pubitemid 35231701)
79. Lawless MW, O'Byrne KJ, and Gray SG. Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy. J Cell Mol Med 13: 2800-2821, 2009.
80. Lazze MC, Pizzala R, Perucca P, Cazzalini O, Savio M, Forti L, Vannini V, and Bianchi L. Anthocyanidins decrease endothelin-1 production and increase endothelial nitric oxide synthase in human endothelial cells. Mol Nutr Food Res 50: 44-51, 2006. (Pubitemid 43158372)
81. Lee B and Moon SK. Resveratrol inhibits TNF-alphainduced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J Nutr 135: 2767-2773, 2005. (Pubitemid 43156539)
82. Lee BW, Chun SW, Kim SH, Lee Y, Kang ES, Cha BS, and Lee HC. Lithospermic acid B protects beta-cells from cytokine-induced apoptosis by alleviating apoptotic pathways and activating anti-apoptotic pathways of Nrf2-HO-1 and Sirt1. Toxicol Appl Pharmacol 252: 47-54, 2011.
83. Lee MJ, Chou FP, Tseng TH, Hsieh MH, Lin MC, and Wang CJ. Hibiscus protocatechuic acid or esculetin can inhibit oxidative LDL induced by either copper ion or nitric oxide donor. J Agric Food Chem 50: 2130-2136, 2002.
84. Levere RD, Martasek P, Escalante B, Schwartzman ML, and Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 86: 213-219, 1990. (Pubitemid 20226994)
85. Li H, Wu S, Shi N, Lian S, and Lin W. Nrf2/HO-1 pathway activation by manganese is associated with reactive oxygen species and ubiquitin-proteasome pathway, not MAPKs signaling. J Appl Toxicol 31: 690-697, 2011.
86. Li Volti G, Sacerdoti D, Di Giacomo C, Barcellona ML, Scacco A, Murabito P, Biondi A, Basile F, Gazzolo D, Abella R, Frigiola A, and Galvano F. Natural heme oxygenase-1 inducers in hepatobiliary function. World J Gastroenterol 14: 6122-6132, 2008.
87. Li Volti G, Seta F, Schwartzman ML, Nasjletti A, and Abraham NG. Heme oxygenase attenuates angiotensin IImediated increase in cyclooxygenase-2 activity in human femoral endothelial cells. Hypertension 41: 715-719, 2003. (Pubitemid 36314580)
88. Li Volti G, Sorrenti V, Murabito P, Galvano F, Veroux M, Gullo A, Acquaviva R, Stacchiotti A, Bonomini F, Vanella L, and Di Giacomo C. Pharmacological induction of heme oxygenase-1 inhibits iNOS and oxidative stress in renal ischemia-reperfusion injury. Transplant Proc 39: 2986-2991 2007. (Pubitemid 350251511)
89. Li Volti G, Zappala A, Leggio GM, Mazzola C, Drago F, La Delia F, Serapide MF, Pellitteri R, Giannone I, Spatuzza M, Cicirata V, and Cicirata F. Tin chloride enhances parvalbumin-positive interneuron survival by modulating heme metabolism in a model of cerebral ischemia. Neurosci Lett 492: 33-38, 2011.
90. Lim JH and Kwon TK. Curcumin inhibits phorbol myristate acetate (PMA)-induced MCP-1 expression by inhibiting ERK and NF-kappaB transcriptional activity. Food Chem Toxicol 48: 47-52, 2010.
91. Lin JK. Molecular targets of curcumin. Adv Exp Med Biol 595: 227-243, 2007.
92. Loke WM, Proudfoot JM, Hodgson JM, McKinley AJ, Hime N, Magat M, Stocker R, and Croft KD. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol 30: 749-757, 2010.
93. Ma J, Phillips L, Wang Y, Dai T, LaPage J, Natarajan R, and Adler SG. Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC. BMC Complement Altern Med 10: 67, 2010.
94. Maines MD. The heme oxygenase system: past, present, and future. Antioxid Redox Signal 6: 797-801, 2004. (Pubitemid 39237931)
95. Manna SK, Mukhopadhyay A, and Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164: 6509-6519, 2000. (Pubitemid 30408836)
96. Mazza GJ. Anthocyanins and heart health. Ann Ist Super Sanita 43: 369-374, 2007.
97. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T, and Dannenberg AJ. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59: 2347-2352, 1999. (Pubitemid 29242281)
98. Mizutani K, Ikeda K, Kawai Y, and Yamori Y. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 46: 78-83, 2000. (Pubitemid 30397400)
99. Morgan MJ and Liu ZG. Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol Cells 30: 1-12, 2010.
100. Ndisang JF and Jadhav A. Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats. Hypertens Res 33: 338-347, 2010.
101. Ogborne RM, Rushworth SA, Charalambos CA, and O'Connell MA. Haem oxygenase-1: a target for dietary antioxidants. Biochem Soc Trans 32: 1003-1005, 2004. (Pubitemid 39655527)
102. Ou J, Ou Z, Jones DW, Holzhauer S, Hatoum OA, Ackerman AW, Weihrauch DW, Gutterman DD, Guice K, Oldham KT, Hillery CA, and Pritchard KA, Jr. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Circulation 107: 2337-2341, 2003. (Pubitemid 36578505)
103. Ou Z, Ou J, Ackerman AW, Oldham KT, and Pritchard KA, Jr. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoproteintreated endothelial cells. Circulation 107: 1520-1524, 2003. (Pubitemid 36378491)
104. Paul B, Masih I, Deopujari J, and Charpentier C. Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India. J Ethnopharmacol 68: 71-76, 1999. (Pubitemid 29502461)
105. Pellegatta F, Bertelli AA, Staels B, Duhem C, Fulgenzi A, and Ferrero ME. Different short- and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells. Am J Clin Nutr 77: 1220-1228, 2003. (Pubitemid 44858439)
106. Penttinen P, Jaehrling J, Damdimopoulos AE, Inzunza J, Lemmen JG, van der Saag P, Pettersson K, Gauglitz G, Makela S, and Pongratz I. Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148: 4875-4886, 2007. (Pubitemid 47481543)
107. Penumathsa SV, Koneru S, Samuel SM, Maulik G, Bagchi D, Yet SF, Menon VP, and Maulik N. Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. Free Radic Biol Med 45: 1027-1034, 2008.
108. Rains JL and Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50: 567-575, 2011.
109. Robich MP, Osipov RM, Chu LM, Han Y, Feng J, Nezafat R, Clements RT, Manning WJ, and Sellke FW. Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia. Eur J Pharmacol 664: 45-53, 2011.
110. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, and Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243: 388-390, 1989. (Pubitemid 19047515)
111. Saija A, Tomaino A, Lo Cascio R, Rapisarda P, and Dederen JC. In vitro antioxidant activity and in vivo photoprotective effect of a red orange extract. Int J Cosmet Sci 20: 331-342 1998. (Pubitemid 29008452)
112. Saiko P, Szakmary A, Jaeger W, and Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 658: 68-94, 2008. (Pubitemid 351172881)
113. Sakata Y, Zhuang H, Kwansa H, Koehler RC, and Dore S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224: 325-329, 2010.
114. Salamone F, Li Volti G, Titta L, Puzzo L, Barbagallo I, La Delia F, Zelber-Sagi S, Malaguarnera M, Pelicci PG, Giorgio M, and Galvano F. Moro orange juice prevents fatty liver in mice. World J Gastroenterol 18: 3862-3868, 2012.
115. Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ, and Motterlini R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 61: 554-561, 2002. (Pubitemid 34171921)
116. Scazzocchio B, Vari R, Filesi C, D'Archivio M, Santangelo C, Giovannini C, Iacovelli A, Silecchia G, Li Volti G, Galvano F, and Masella R. Cyanidin-3-O-beta-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARgamma activity in human omental adipocytes. Diabetes 60: 2234-2244, 2011.
117. Schantz M, Erk T, and Richling E. Metabolism of green tea catechins by the human small intestine. Biotechnol J 5: 1050-1059, 2010.
118. Seki T, Naruse M, Naruse K, Yoshimoto T, Tanabe A, Seki M, Tago K, Imaki T, Demura R, and Demura H. Induction of heme oxygenase produces load-independent cardioprotective effects in hypertensive rats. Life Sci 65: 1077-1086, 1999. (Pubitemid 29410392)
119. Selvam C, Jachak SM, Thilagavathi R, and Chakraborti AK. Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents. Bioorg Med Chem Lett 15: 1793-1797, 2005. (Pubitemid 40380734)
120. Shen MY, Hsiao G, Liu CL, Fong TH, Lin KH, Chou DS, and Sheu Jr. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Br J Haematol 139: 475-485, 2007. (Pubitemid 47512173)
121. Sies H, Stahl W, and Sundquist AR. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann N Y Acad Sci 669: 7-20, 1992. (Pubitemid 23009923)
122. Sohal RS and Orr WC. Relationship between antioxidants, prooxidants, and the aging process. Ann N Y Acad Sci 663: 74-84, 1992. (Pubitemid 23090526)
123. Sohal RS and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273: 59-63, 1996. (Pubitemid 26255420)
124. Soleas GJ, Diamandis EP, and Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem 30: 91-113, 1997. (Pubitemid 27180922)
125. Son S and Lewis BA. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J Agric Food Chem 50: 468-472, 2002. (Pubitemid 34106663)
126. Sorrenti V, Mazza F, Campisi A, Di Giacomo C, Acquaviva R, Vanella L, and Galvano F. Heme oxygenase induction by cyanidin-3-O-beta-glucoside in cultured human endothelial cells. Mol Nutr Food Res 51: 580-586, 2007. (Pubitemid 47083695)
127. Tan J, Ma Z, Han L, Du R, Zhao L, Wei X, Hou D, Johnstone BH, Farlow MR, and Du Y. Caffeic acid phenethyl ester possesses potent cardioprotective effects in a rabbit model of acute myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 289: H2265-H2271, 2005. (Pubitemid 41507382)
128. Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK, and Maulik N. Resveratrol alleviates cardiac dysfunction in streptozotocininduced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43: 720-729, 2007. (Pubitemid 47102122)
129. Tkachev VO, Menshchikova EB, and Zenkov NK. Mechanism of the Nrf2/Keap1/ARE signaling system. Biochemistry (Mosc) 76: 407-422, 2011.
130. Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, Knight RA, Latchman DS, and Stephanou A. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusioninduced apoptosis. FASEB J 18: 1621-1623, 2004. (Pubitemid 39561653)
131. Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, and Moore MA. Cancer prevention by natural compounds. Drug Metab Pharmacokinet 19: 245-263 2004.
132. Tsutsui H, Kinugawa S, and Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301: H2181-H2190, 2011.
133. Turrens JF. The potential of antioxidant enzymes as pharmacological agents in vivo. Xenobiotica 21: 1033-1040, 1991.
134. Tzen JT, Jinn TR, Chen YC, Li FY, Cheng FC, Shi LS, She H, Chen BC, Hsieh V, and Tu ML. Magnesium lithospermate B possesses inhibitory activity on Na +, K + -ATPase and neuroprotective effects against ischemic stroke. Acta Pharmacol Sin 28: 609-615, 2007. (Pubitemid 46691096)
135. Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S, Podlutsky A, and Csiszar A. Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol 292: H2417-H2424, 2007. (Pubitemid 47084624)
136. Vanharanta M, Voutilainen S, Nurmi T, Kaikkonen J, Roberts LJ, Morrow JD, Adlercreutz H, and Salonen JT. Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis 160: 465-469, 2002. (Pubitemid 34159342)
137. Vecoli C, Cao J, Neglia D, Inoue K, Sodhi K, Vanella L, Gabrielson KK, Bedja D, Paolocci N, L'Abbate A, and Abraham NG. Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice. J Cell Biochem 112: 2616-2626, 2011.
138. Vidavalur R, Otani H, Singal PK, and Maulik N. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 11: 217-225 2006. (Pubitemid 44540866)
139. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh DG, Ford R, Spinale FG, Riggs DW, Srivastava S, Bhatnagar A, Bolli R, and Prabhu SD. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 121: 1912-1925, 2010.
140. Wang LQ. Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777: 289-309, 2002.
141. Wang S, Qian Y, Gong D, Zhang Y, and Fan Y. Resveratrol attenuates acute hypoxic injury in cardiomyocytes: correlation with inhibition of iNOS-NO signaling pathway. Eur J Pharm Sci 44: 416-421, 2011.
142. Wang X, Stavchansky S, Kerwin SM, and Bowman PD. Structure-activity relationships in the cytoprotective effect of caffeic acid phenethyl ester (CAPE) and fluorinated derivatives: effects on heme oxygenase-1 induction and antioxidant activities. Eur J Pharmacol 635: 16-22, 2010.
143. Wei X, Zhao L, Ma Z, Holtzman DM, Yan C, Dodel RC, Hampel H, Oertel W, Farlow MR, and Du Y. Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. Brain 127: 2629-2635, 2004. (Pubitemid 39627372)
144. Worou ME, Belmokhtar K, Bonnet P, Vourc'h P, Machet MC, Khamis G, and Eder V. Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling. Cardiovasc Res 91: 320-329, 2011.
145. Xiao K, Song QH, Zhang SW, and Xuan LJ. Water-soluble constituents of the root barks of Fraxinus rhynchophylla (Chinese drug Qinpi). J Asian Nat Prod Res 10: 205-210, 2008. (Pubitemid 351207822)
146. Yang C, Zhang X, Fan H, and Liu Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 1282: 133-141, 2009.
147. Yang L, Quan S, and Abraham NG. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am J Physiol 277: L127-L133, 1999. (Pubitemid 29356759)
148. Yang Y, Wang X, Zhang L, An H, and Zao Z. Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets. Am J Chin Med 39: 145-159, 2011.
149. Yeh CH, Chen TP, Wang YC, Lin YM, and Lin PJ. HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-kappaB and AP-1 translocation following cardiac global ischemia and reperfusion. J Surg Res 155: 147-156, 2009.
150. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, and Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362: 2155-2165, 2010.
151. Yoshida Y, Shioi T, and Izumi T. Resveratrol ameliorates experimental autoimmune myocarditis. Circ J 71: 397-404 2007. (Pubitemid 46409545)
152. Young AJ and Lowe GM. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 385: 20-27 2001. (Pubitemid 32988978)
153. Zeng B, Chen H, Zhu C, Ren X, Lin G, and Cao F. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. Eur J Cardiothorac Surg 34: 850-856, 2008.
154. Zghonda N, Yoshida S, Araki M, Kusunoki M, Mliki A, Ghorbel A, and Miyazaki H. Greater effectiveness of epsilon-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration. Biosci Biotechnol Biochem 75: 1259-1267, 2011.
155. Zheng Y, Toborek M, and Hennig B. Epigallocatechin gallate-mediated protection against tumor necrosis factoralpha-induced monocyte chemoattractant protein-1 expression is heme oxygenase-1 dependent. Metabolism 59: 1528-1535 2010.
156. Zhu H, Itoh K, Yamamoto M, Zweier JL, and Li Y. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Lett 579: 3029-3036, 2005. (Pubitemid 40797830)